Investor Alert: Argentina Loaded With "White Gold" Opportunity
Experts expect the global lithium market to grow by 500% due to the explosion of electric vehicles and green energy. And one small-cap company just snagged a large lithium deposit in a renowned South American location.
Read about this once-in-a-lifetime opportunity

ADIL Insider Trading (Adial Pharmaceuticals)

Insider Ownership Percentage: 25.26%
Insider Buying (Last 12 Months): $54,400.00
Insider Selling (Last 12 Months): $0.00

Adial Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Adial Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Adial Pharmaceuticals Share Price & Price History

Current Price: $1.36
Price Change: Price Increase of +0.08 (6.25%)
As of 05/16/2022 01:18 PM ET

This chart shows the closing price history over time for ADIL up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
27 U.S. Cities Where Stocks Yield 26% a Year
What’s the highest-yielding stock you’ve ever owned? The dividends for these stocks have risen so fast over the years that they’re now yielding us an average of 26%!

When you start getting paid 26% on your money, your financial problems tend to pretty much evaporate.
Get in on the action here.

Adial Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/29/2021William B. Stilley, IIICEOBuy10,000$2.59$25,900.00View SEC Filing Icon  
11/26/2021James W. Newman, Jr.DirectorBuy10,000$2.85$28,500.00View SEC Filing Icon  
4/6/2021Bankole A. JohnsonInsiderSell150,000$2.50$375,000.001,055View SEC Filing Icon  
3/27/2020James W. Newman, Jr.DirectorBuy19,644$1.28$25,144.3215,000View SEC Filing Icon  
3/25/2020William B. Stilley, IIICEOBuy12,348$1.13$13,953.24703,285View SEC Filing Icon  
12/12/2019Bankole A. JohnsonInsiderSell150,000$1.00$150,000.00351,055View SEC Filing Icon  
See Full Table
"The Most Critical Metal for Global Economies"
The soaring demand for this "red rock" may be the most important development in 2022. It's key in the transition to the new green energy economies. Bloomberg News warns… "Within a decade, the world may face a massive shortfall of what's arguably the most critical metal for global economies." Copper prices have nearly doubled in the past year.
Find Out How This Is Good News

SEC Filings (Institutional Ownership Changes) for Adial Pharmaceuticals (NASDAQ:ADIL)

10.06% of Adial Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ADIL by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Adial Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/13/2022Renaissance Technologies LLC19,958$40K0.0%N/A0.084%Search for SEC Filing on Google Icon
5/13/2022Empirical Financial Services LLC d.b.a. Empirical Wealth Management35,000$70K0.0%N/A0.148%Search for SEC Filing on Google Icon
2/23/2022BlackRock Inc.227,178$0.61M0.0%+16.3%1.094%Search for SEC Filing on Google Icon
2/17/2022Goldman Sachs Group Inc.19,526$53K0.0%N/A0.094%Search for SEC Filing on Google Icon
2/14/2022Goldman Sachs Group Inc.19,526$53K0.0%N/A0.094%Search for SEC Filing on Google Icon
2/11/2022Geode Capital Management LLC129,327$0.35M0.0%+34.6%0.623%Search for SEC Filing on Google Icon
11/16/2021Millennium Management LLC17,049$73K0.0%N/A0.084%Search for SEC Filing on Google Icon
11/15/2021Morgan Stanley40,228$0.17M0.0%+7,419.3%0.198%Search for SEC Filing on Google Icon
11/12/2021Oppenheimer & Co. Inc.38,500$0.17M0.0%+37.5%0.190%Search for SEC Filing on Google Icon
11/12/2021Geode Capital Management LLC96,077$0.41M0.0%+8.9%0.473%Search for SEC Filing on Google Icon
11/12/2021NorthRock Partners LLC10,000$43K0.0%N/A0.049%Search for SEC Filing on Google Icon
10/29/2021Commonwealth Equity Services LLC36,461$0.16M0.0%+25.5%0.180%Search for SEC Filing on Google Icon
9/17/2021Virtu Financial LLC31,038$79K0.0%N/A0.153%Search for SEC Filing on Google Icon
8/17/2021Citadel Advisors LLC20,198$52K0.0%-72.8%0.107%Search for SEC Filing on Google Icon
8/16/2021State Street Corp48,954$0.13M0.0%N/A0.260%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp21,873$56K0.0%N/A0.116%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC88,246$0.23M0.0%+13.2%0.469%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.585,035$1.49M0.0%+172.4%3.112%Search for SEC Filing on Google Icon
8/11/2021Commonwealth Equity Services LLC29,050$74K0.0%+31.7%0.155%Search for SEC Filing on Google Icon
8/3/2021Oppenheimer & Co. Inc.28,000$71K0.0%+93.1%0.152%Search for SEC Filing on Google Icon
7/17/2021Golden Green Inc.24,700$63K0.0%N/A0.134%Search for SEC Filing on Google Icon
5/14/2021Dimensional Fund Advisors LP31,410$76K0.0%+68.8%0.179%Search for SEC Filing on Google Icon
5/13/2021Barclays PLC15,850$38K0.0%N/A0.091%Search for SEC Filing on Google Icon
5/12/2021Rede Wealth LLC15,000$36K0.0%N/A0.086%Search for SEC Filing on Google Icon
5/10/2021Oppenheimer & Co. Inc.14,500$35K0.0%N/A0.083%Search for SEC Filing on Google Icon
5/4/2021Commonwealth Equity Services LLC22,050$53K0.0%+107.3%0.126%Search for SEC Filing on Google Icon
4/22/2021Private Advisor Group LLC36,650$89K0.0%N/A0.212%Search for SEC Filing on Google Icon
3/8/2021Dimensional Fund Advisors LP18,612$32K0.0%N/A0.129%Search for SEC Filing on Google Icon
2/25/2021Dimensional Fund Advisors LP18,612$32K0.0%N/A0.129%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC98,900$0.17M0.0%+6.5%0.687%Search for SEC Filing on Google Icon
12/11/2020Virtu Financial LLC18,902$42K0.0%N/A0.131%Search for SEC Filing on Google Icon
8/14/2020Bank of America Corp DE150,000$0.21M0.0%N/A1.115%Search for SEC Filing on Google Icon
8/14/2019Vanguard Group Inc.293,908$0.49M0.0%-3.2%2.875%Search for SEC Filing on Google Icon
2/14/2019Two Sigma Investments LP11,775$60K0.0%N/A0.180%Search for SEC Filing on Google Icon
2/13/2019Geode Capital Management LLC13,581$69K0.0%N/A0.207%Search for SEC Filing on Google Icon
2/8/2019BlackRock Inc.205,684$1.05M0.0%N/A3.137%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Adial Pharmaceuticals logo
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.
Read More on Adial Pharmaceuticals

Today's Range

Now: $1.36
Low: $1.33
High: $1.36

50 Day Range

MA: $1.72
Low: $1.19
High: $2.13

52 Week Range

Now: $1.36
Low: $1.14
High: $5.08

Volume

883 shs

Average Volume

118,141 shs

Market Capitalization

$32.26 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.83

Who are the company insiders with the largest holdings of Adial Pharmaceuticals?

Adial Pharmaceuticals' top insider shareholders include:
  1. Bankole A Johnson (Insider)
  2. James W Jr Newman (Director)
  3. William B Stilley III (CEO)
Learn More about top insider investors at Adial Pharmaceuticals.

Who are the major institutional investors of Adial Pharmaceuticals?

Adial Pharmaceuticals' top institutional investors include:
  1. Empirical Financial Services LLC d.b.a. Empirical Wealth Management — 0.15%
  2. Renaissance Technologies LLC — 0.08%
Learn More about top institutional investors of Adial Pharmaceuticals stock.

Which institutional investors are buying Adial Pharmaceuticals stock?

Within the last quarter, ADIL stock was acquired by institutional investors including:
  1. Empirical Financial Services LLC d.b.a. Empirical Wealth Management
  2. Renaissance Technologies LLC
Within the previous year, these company insiders have bought Adial Pharmaceuticals stock:
  1. Bankole A Johnson (Insider)
  2. James W Jr Newman (Director)
Learn More investors buying Adial Pharmaceuticals stock.
Investor Alert: Argentina Loaded With "White Gold" Opportunity
Experts expect the global lithium market to grow by 500% due to the explosion of electric vehicles and green energy. And one small-cap company just snagged a large lithium deposit in a renowned South American location.
Read about this once-in-a-lifetime opportunity